Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The Effect of Ethnic on Moxifloxacin Induced QT Interval Prolongation in Korean and Japanese Healthy Subjects
The purpose of this study is to explore the ethnic and gender difference in the Moxifloxacin induced QT interval prolongation between Japanese and Korean subjects.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Moxifloxacin | Active Comparator | single oral administration of 400mg of moxifloxacin |
|
| Placebo | Placebo Comparator | single oral administration of 400mg of placebo |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Moxifloxacin | Drug | single oral administration of 400mg of moxifloxacin |
|
| Measure | Description | Time Frame |
|---|---|---|
| double delta QTcF | 12 point of ECG measurements according to the interventions | up to 24 hours |
| Measure | Description | Time Frame |
|---|---|---|
| double delta QTcI, double delta QTcSS | up to 24 hours |
Not provided
Inclusion Criteria:
- 1) Subjects in Japan and Korea deemed healthy as determined by no clinically significant deviation from normal in medical history, physical examination, ECGs, or clinical laboratory determinations.
2) Body Mass Index (BMI) of 17.6 to 26.4 kg/m2, BMI = weight (kg)/ [height (m)]2.
Exclusion Criteria:
1) Evidence of organ dysfunction or any clinically significant deviation from normal in physical examination, vital signs, ECG or clinical laboratory determinations beyond what is consistent with the target population.
2) Any of the following on 12-lead ECG prior to study drug administration, confirmed by repeat.
Heart rate ≤ 45 bpmmsec or Heart rate ≥ 100 bpmmsec
PR ≥ 210 msec
QRS ≥ 120 msec
QT ≥ 500 msec
QTcF: male ≥ 450 msec, female ≥470msec
Iincomplete right bundle branch block
Marked Sinus Arrhythmia
Wondering pacemaker
Atrial rhythm
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Jae-Gook Shin, MD, PhD | Inje University | Principal Investigator |
Not provided
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 28003052 | Derived | Choi HK, Jung JA, Fujita T, Amano H, Ghim JL, Lee DH, Tabata K, Song ID, Maeda M, Kumagai Y, Mendzelevski B, Shin JG. Population Pharmacokinetic-Pharmacodynamic Analysis to Compare the Effect of Moxifloxacin on QT Interval Prolongation Between Healthy Korean and Japanese Subjects. Clin Ther. 2016 Dec;38(12):2610-2621. doi: 10.1016/j.clinthera.2016.10.011. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000077266 | Moxifloxacin |
| D007785 | Lactose |
| ID | Term |
|---|---|
| D024841 | Fluoroquinolones |
| D042462 | 4-Quinolones |
| D015363 | Quinolones |
| D011804 | Quinolines |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Placebo | Drug | single oral administration of 400mg of placebo |
|
|
| D006574 |
| Heterocyclic Compounds, 2-Ring |
| D000072471 | Heterocyclic Compounds, Fused-Ring |
| D006571 | Heterocyclic Compounds |
| D004187 | Disaccharides |
| D009844 | Oligosaccharides |
| D011134 | Polysaccharides |
| D002241 | Carbohydrates |
| D000073893 | Sugars |